Computational AI tool for predicting therapy response
The clinical, biochemical and genetic data generated in the PoCCardio clinical trial are used to develop a computational AI-based tool for predicting the risk of a heart attack and therapy response in patients.
The clinical trial has started
13 out of 29 study centres in Austria, Germany and Poland have begun recruiting participants for the trial of the PoCCardio point-of-care solution.
Ambient Temperature and the Frequency of Subsequent Heart Failure Decompensations in an Emergency Department
The journal paper is co-authored by the Medical University of Graz for MDPI Biomedicines
Novel clustering algorithm for enhancing the interpretability in patient stratification
The paper was prepared by the Medical University of Graz for the CIBB 2024 conference on Computational Intelligence methods for Bioinformatics and Biostatistics.
A new project partner
PoCCardio welcomes the Bioinformatics Department at CING - The Cyprus Institute of Neurology and Genetics
Project leaflet released
Have a look at our leaflet
